Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices 43569 

Register pursuant to Section 6(b) of the 

Act on June 28, 2017 (82 FR 29328). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2017–19791 Filed 9–15–17; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—fd.Io Project, Inc. 

Notice is hereby given that, on August 

24, 2017, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), fd.io Project, Inc. 

(‘‘fd.io’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, ARM Ltd., Cambridge, 

UNITED KINGDOM; Linaro Limited, 

Cambridge, UNITED KINGDOM; 

Rubicon Communications LLC dba 

Netgate, Austin, TX; and CENGN 

(Centre of Excellence in Next 

Generation Networks), Ottawa, 

CANADA, have been added as parties to 

this venture. 

Also, Brocade Communications 

Systems, Inc., San Jose, CA, has 

withdrawn as a party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and fd.io intends 

to file additional written notifications 

disclosing all changes in membership. 

On May 4, 2016, fd.io filed its original 

notification pursuant to Section 6(a) of 

the Act. The Department of Justice 

published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 9, 2016 (81 FR 37211). 

The last notification was filed with 

the Department on May 30, 2017. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 28, 2017 (82 FR 29329). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2017–19789 Filed 9–15–17; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: AMPAC Fine 

Chemicals LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.33(a) on 

or before November 17, 2017. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on August 

16, 2017, AMPAC Fine Chemicals LLC, 

Highway 50 and Hazel Avenue, 

Building 05001, Rancho Cordova, 

California 95670 applied to be registered 

as a bulk manufacturer of 

levomethorphan (9210), a basic class of 

controlled substance in schedule II. 

The company plans to manufacture 

the listed controlled substance as an 

intermediate in the bulk manufacture of 

other controlled substances for 

distribution to its customers. 

Dated: September 11, 2017. 

Demetra Ashley, 

Acting Assistant Administrator. 

[FR Doc. 2017–19831 Filed 9–15–17; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Catalent Centers, LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before October 18, 2017. Such 

persons may also file a written request 

for a hearing on the application 

pursuant to 21 CFR 1301.43 on or before 

October 18, 2017. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on July 25, 

2017, Catalent Centers, LLC, 10245 

Hickman Mills Drive, Kansas City, 

Missouri 64137 applied to be registered 

as an importer of the following basic 

classes of controlled substances: 


sradovich on DSKBBY8HB2PROD with NOTICES